المؤلفون: Avkshtol V, Dong Y, Hayes SB, Hallman MA, Price RA, Sobczak ML, Horwitz EM, Zaorsky NG

المصدر: Research and Reports in Urology, Vol Volume 8, Pp 145-158 (2016)

مصطلحات موضوعية: Prostate cancer, stereotactic body radiation therapy, technology, quality of life, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

Relation: https://www.dovepress.com/a-comparison-of-robotic-arm-versus-gantry-linear-accelerator-stereotac-peer-reviewed-article-RRU; https://doaj.org/toc/2253-2447

URL الوصول: https://doaj.org/article/9e506a6cb14742e1bde79432751597ac

المؤلفون: Hjorth Fredrik Universitetsadjunkt, Hjorth Fredrik Universitetsadjunkt, Högskolan i Kalmar Sjöfartshögskolan, Hallman Mattias 1984- , Högskolan i Kalmar, Sjöfartshögskolan, Hanner Tony 1979- , Högskolan i Kalmar, Sjöfartshögskolan

URL الوصول: https://www.europeana.eu/item/9200111/BibliographicResource_1000085987792?utm_source=api&utm_medium=api&utm_campaign=YuvuWBeCa

المؤلفون: Hallman Mattias 1984-, Högskolan i Kalmar, Sjöfartshögskolan, Hanner Tony 1979-, Högskolan i Kalmar, Sjöfartshögskolan, Hallman Mattias 1984-, The University of Kalmar, Sjöfarti

المساهمون: Hjorth Fredrik Universitetsadjunkt, Högskolan i Kalmar Sjöfartshögskolan, The University of Kalmar Sjöfartög

المؤلفون: Hallman Magnus, Bartolozzi Francesco, Ogborne John

URL الوصول: https://www.europeana.eu/item/2058635/_pau_oai_pauart_pl_559bbd350cf2c6aee07b5902?utm_source=api&utm_medium=api&utm_campaign=YuvuWBeCa

المؤلفون: Lee CT; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA. Electronic address: charles.lee@fccc.edu., Koleoso O; Doctor of Osteopathic Medicine Program, Philadelphia College of Osteopathic Medicine, Philadelphia, PA., Deng M; Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, PA., Veltchev I; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA., Lin T; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA., Hallman MA; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA., Horwitz EM; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA., Wong JK; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA.

المصدر: Brachytherapy [Brachytherapy] 2023 Sep-Oct; Vol. 22 (5), pp. 586-592. Date of Electronic Publication: 2023 Jun 30.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier, 2002- Country of Publication: United States NLM ID: 101137600 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-1449 (Electronic) Linking ISSN: 15384721 NLM ISO Abbreviation: Brachytherapy Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy*/methods , Prostatic Neoplasms*/radiotherapy, Male ; Humans ; Hydrogels ; Radiotherapy Dosage ; Radiometry ; Rectum

المؤلفون: Hahn NM; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA. Electronic address: nhahn4@jhmi.edu., O'Donnell MA; University of Iowa Carver College of Medicine, Iowa City, IA, USA., Efstathiou JA; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Zahurak M; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Rosner GL; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Smith J; Hoosier Cancer Research Network, Indianapolis, IN, USA., Kates MR; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Bivalacqua TJ; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA; Division of Urology and Urologic Surgery, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Tran PT; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA; Department of Radiation Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA., Song DY; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA; Department of Radiation Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Baras AS; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Matoso A; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Choi W; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Smith KN; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; Johns Hopkins Bloomberg Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA., Pardoll DM; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; Johns Hopkins Bloomberg Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA., Marchionni L; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; Johns Hopkins University School of Medicine, Center for Computational Genomics, Baltimore, MD, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA., McGuire B; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Grace Phelan M; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Johnson BA 3rd; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., O'Neal T; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., McConkey DJ; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Rose TL; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA; Division of Medical Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA., Bjurlin M; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA; Department of Urology, University of North Carolina, Chapel Hill, NC, USA., Lim EA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Spectrum Health Medical Group, Grand Rapids, MI, USA., Drake CG; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Janssen Research and Development, Springhouse, PA, USA., McKiernan JM; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Department of Urology, Columbia University, New York, NY, USA., Deutsch I; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Department of Radiation Oncology, Columbia University, New York, NY, USA., Anderson CB; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Department of Urology, Columbia University, New York, NY, USA., Lamm DL; BCG Oncology, Phoenix, AZ, USA., Geynisman DM; Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Plimack ER; Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Hallman MA; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Horwitz EM; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Al-Saleem E; Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA., Chen DYT; Department of Urology, Fox Chase Cancer Center, Philadelphia, PA, USA., Greenberg RE; Department of Urology, Fox Chase Cancer Center, Philadelphia, PA, USA., Kutikov A; Department of Urology, Fox Chase Cancer Center, Philadelphia, PA, USA., Guo G; Department of Radiation Oncology, Indiana University Simon Cancer Center, Indianapolis, IN, USA; University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Masterson TA; Department of Urology, Indiana University Simon Cancer Center, Indianapolis, IN, USA., Adra N; Division of Hematology and Oncology, Indiana University Simon Cancer Center, Indianapolis, IN, USA., Kaimakliotis HZ; Department of Urology, Indiana University Simon Cancer Center, Indianapolis, IN, USA.

المصدر: European urology [Eur Urol] 2023 Jun; Vol. 83 (6), pp. 486-494. Date of Electronic Publication: 2023 Jan 28.

نوع المنشور: Clinical Trial, Phase I; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

مواضيع طبية MeSH: Non-Muscle Invasive Bladder Neoplasms* , Urinary Bladder Neoplasms*/pathology, Humans ; Urinary Bladder/pathology ; BCG Vaccine/adverse effects ; Administration, Intravesical ; Adjuvants, Immunologic ; Neoplasm Invasiveness/pathology ; Neoplasm Recurrence, Local/pathology

المؤلفون: Zhang E; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Ruth KJ; Department of Biostatistics, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Buyyounouski MK; Department of Radiation Oncology, Stanford University, Stanford, California., Price RA Jr; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Uzzo RG; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Sobczak ML; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Pollack A; Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, Florida., Wong JK; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Chen DYT; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Hallman MA; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Greenberg RE; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Watkins-Bruner D; Emory University, Atlanta, Georgia., Al-Saleem T; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Horwitz EM; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Electronic address: eric.horwitz@fccc.edu.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Apr 01; Vol. 115 (5), pp. 1074-1084. Date of Electronic Publication: 2022 Dec 23.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Radiotherapy, Intensity-Modulated*/adverse effects , Radiotherapy, Intensity-Modulated*/methods , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/pathology , Erectile Dysfunction*/etiology, Male ; Humans ; Prospective Studies ; Radiotherapy Dosage ; Androgen Antagonists ; Single-Blind Method

المؤلفون: Pirlamarla AK; Departments of Radiation Oncology., Hansen CC; Departments of Radiation Oncology., Deng M; Biostatistics., Handorf E; Biostatistics., Paly J; Departments of Radiation Oncology., Wong JK; Departments of Radiation Oncology., Hallman MA; Biostatistics., Chen DYT; Urologic Oncology., Geynisman DM; Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Kutikov A; Urologic Oncology., Horwitz EM; Departments of Radiation Oncology. Electronic address: eric.horwitz@fccc.edu.

المصدر: Practical radiation oncology [Pract Radiat Oncol] 2022 Jan-Feb; Vol. 12 (1), pp. 60-67. Date of Electronic Publication: 2021 Jul 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101558279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-8519 (Electronic) Linking ISSN: 18798500 NLM ISO Abbreviation: Pract Radiat Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy* , Prostatic Neoplasms*/radiotherapy, Follow-Up Studies ; Humans ; Kinetics ; Male ; Prostate-Specific Antigen/metabolism ; Retrospective Studies

المؤلفون: Ginsburg KB; Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia PA., Chandra AA; Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia PA., Schober JP; Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia PA., Handorf EA; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia PA., Uzzo RG; Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia PA., Greenberg RE; Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia PA., Chen DY; Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia PA., Viterbo R; Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia PA., Smaldone MC; Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia PA., Kutikov A; Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia PA., Hallman MA; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia PA., Correa AF; Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia PA. Electronic address: Andres.correa@fccc.edu.

المصدر: Urologic oncology [Urol Oncol] 2021 Nov; Vol. 39 (11), pp. 791.e1-791.e7. Date of Electronic Publication: 2021 Jul 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Adrenocortical Carcinoma/*radiotherapy, Adrenocortical Carcinoma/mortality ; Databases, Factual ; Female ; Humans ; Male ; Radiotherapy, Adjuvant ; Retrospective Studies ; Risk Factors ; Survival Analysis ; United States

المؤلفون: Paly JJ; Departments of Radiation Oncology., Egleston BL; Biostatistics., Wong JK; Departments of Radiation Oncology., Burbure N; Departments of Radiation Oncology., Sobczak ML; Departments of Radiation Oncology., Hayes SB; Departments of Radiation Oncology., Chen DYT; Urology, Fox Chase Cancer Center, Philadelphia, PA., Horwitz EM; Departments of Radiation Oncology., Hallman MA; Departments of Radiation Oncology.

المصدر: American journal of clinical oncology [Am J Clin Oncol] 2021 Apr 01; Vol. 44 (4), pp. 131-136.

نوع المنشور: Comparative Study; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print Cited Medium: Internet ISSN: 1537-453X (Electronic) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Patient Reported Outcome Measures* , Quality of Life*, Adenocarcinoma/*radiotherapy , Brachytherapy/*psychology , Prostatic Neoplasms/*radiotherapy , Radiosurgery/*psychology, Adenocarcinoma/psychology ; Adult ; Aged ; Aged, 80 and over ; Brachytherapy/methods ; Dose Fractionation, Radiation ; Humans ; Male ; Middle Aged ; Prospective Studies ; Prostatic Neoplasms/psychology ; Radiation Injuries/etiology ; Radiation Injuries/psychology ; Radiotherapy Dosage ; Severity of Illness Index ; Sexual Dysfunction, Physiological/etiology ; Sexual Dysfunction, Physiological/psychology ; Surveys and Questionnaires ; Treatment Outcome ; Urination Disorders/etiology ; Urination Disorders/psychology